SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon enters into partnership with Sandoz

18 Jan 2018 Evaluate

Biocon has entered into partnership with Sandoz, a Novartis division and a global leader in biosimilars, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

Under the terms of the agreement, both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally. Worldwide commercialization responsibilities will be divided and each company's strengths will be leveraged within specific geographies. Sandoz will lead commercialization in North America (US and Canada) and the EU (including European Free Trade Association (EFTA) and Balkan states), while Biocon will lead commercialization in Rest of the World (including India, Russia and Commonwealth of Independent States (CIS)).

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

380.45 11.55 (3.13%)
06-May-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1853.20
Dr. Reddys Lab 1322.35
Cipla 1368.45
Zydus Lifesciences 939.40
Lupin 2445.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×